$SPTX SEC Filings

Filed On	Filing
14 Aug 2026	SCHEDULE 13G
05 Aug 2026	SCHEDULE 13G
05 Aug 2026	SCHEDULE 13G
03 Aug 2026	10-Q
03 Aug 2026	8-K: Results of Operations and Financial Condition
24 Jun 2026	Form 4: Hombach Robert J., Director Bought 13,000 shares ($236K)
08 Jun 2026	10-Q
08 Jun 2026	8-K: Results of Operations and Financial Condition
11 May 2026	SCHEDULE 13D
11 May 2026	SCHEDULE 13G
06 May 2026	Form 3: Gap Coinvestments CDA, L.p., Director and 3 others Holds 6,101,582 shares of Common Stock, par value $0.0001 per share ("Common Stock")
06 May 2026	Form 3: General Atlantic (SP), L.p., Director and 9 others Holds 6,101,582 shares of Common Stock, par value $0.0001 per share ("Common Stock")
06 May 2026	Form 4: PureTech Health plc, 10% owner and 1 other Received 16,382,534 shares by conversion
06 May 2026	SCHEDULE 13D
04 May 2026	Form 4: Zohar Daphne, Director Granted 1,758,599 Stock Option (Right to Buy)
04 May 2026	Form 4: Healy James, Director Received 2,731,538 shares by conversion
04 May 2026	Form 4: White Lauren, Chief Financial Officer Granted 63,680 Stock Option (Right to Buy) · Received 6,702 shares by conversion
04 May 2026	Form 4: Wheadon David E., Director Granted 12,258 Stock Option (Right to Buy)
04 May 2026	Form 4: Peterson Sandra E, Director Granted 12,258 Stock Option (Right to Buy)
04 May 2026	Form 4: Gladstein Lana, General Counsel Granted 63,680 Stock Option (Right to Buy) · Received 33,515 shares by conversion

Comments